{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:07:18Z","timestamp":1789967238375,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02361610"],"award-info":[{"award-number":["RF-2016-02361610"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autosomal dominant optic atrophy (ADOA) is a neuro-ophthalmic condition characterized by bilateral degeneration of the optic nerves. Although heterozygous mutations in <jats:italic>OPA1<\/jats:italic> represent the most common genetic cause of ADOA, a significant number of cases remain undiagnosed.<\/jats:p><jats:p>Here, we describe a family with a strong ADOA history with most family members spanning three generation having childhood onset of visual symptoms. The proband, in addition to optic atrophy, had neurological symptoms consistent with relapsing remitting multiple sclerosis. Clinical exome analysis detected a novel mutation in the <jats:italic>AFG3L2<\/jats:italic> gene (NM_006796.2:c.1010G\u2009&gt;\u2009A; p.G337E), which segregated with optic atrophy in family members. AFG3L2 is a metalloprotease of the AAA subfamily which exerts quality control in the inner mitochondrial membrane. Interestingly, the identified mutation localizes close to the AAA domain of AFG3L2, while those localized in the proteolytic domain cause dominant spinocerebellar ataxia type 28 (SCA28) or recessive spastic ataxia with epilepsy (SPAX5)<jats:italic>.<\/jats:italic> Functional studies in patient fibroblasts demonstrate that the p.G337E AFG3L2 mutation strongly destabilizes the long isoforms of OPA1 via OMA hyper-activation and leads to mitochondrial fragmentation, thus explaining the family phenotype. This study widens the clinical spectrum of neurodegenerative diseases caused by <jats:italic>AFG3L2<\/jats:italic> mutations, which shall be considered as genetic cause of ADOA.<\/jats:p>","DOI":"10.1186\/s40478-020-00975-w","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T13:03:52Z","timestamp":1593435832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy"],"prefix":"10.1186","volume":"8","author":[{"given":"Valentina","family":"Baderna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa S.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryony A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Ruddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamira","family":"Huq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8095-8208","authenticated-orcid":false,"given":"Francesca","family":"Maltecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"975_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1750-1172-7-46","volume":"7","author":"G Lenaers","year":"2012","unstructured":"Lenaers G et al (2012) Dominant optic atrophy. Orphanet J Rare Dis 7:46","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"975_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ajo.2006.12.038","volume":"143","author":"AC Cohn","year":"2007","unstructured":"Cohn AC et al (2007) Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. Am J Ophthalmol 143(4):656\u2013662","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"975_CR3","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1242\/jcs.159186","volume":"129","author":"T MacVicar","year":"2016","unstructured":"MacVicar T, Langer T (2016) OPA1 processing in cell death and disease - the long and short of it. J Cell Sci 129(12):2297\u20132306","journal-title":"J Cell Sci"},{"issue":"6","key":"975_CR4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1083\/jcb.201308006","volume":"204","author":"R Anand","year":"2014","unstructured":"Anand R et al (2014) The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J Cell Biol 204(6):919\u2013929","journal-title":"J Cell Biol"},{"issue":"7","key":"975_CR5","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ncb3560","volume":"19","author":"T Ban","year":"2017","unstructured":"Ban T et al (2017) Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin. Nat Cell Biol 19(7):856\u2013863","journal-title":"Nat Cell Biol"},{"issue":"6","key":"975_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm3984","volume":"16","author":"PM Quiros","year":"2015","unstructured":"Quiros PM, Langer T, Lopez-Otin C (2015) New roles for mitochondrial proteases in health, ageing and disease. Nat Rev Mol Cell Biol 16(6):345\u2013359","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"975_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/jmedgenet-2018-105766","volume":"56","author":"S Tulli","year":"2019","unstructured":"Tulli S et al (2019) Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation. J Med Genet 56(8):499\u2013511","journal-title":"J Med Genet"},{"issue":"4","key":"975_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/ng.544","volume":"42","author":"D Di Bella","year":"2010","unstructured":"Di Bella D et al (2010) Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet 42(4):313\u2013321","journal-title":"Nat Genet"},{"issue":"10","key":"975_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002325","volume":"7","author":"TM Pierson","year":"2011","unstructured":"Pierson TM et al (2011) Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genet 7(10):e1002325","journal-title":"PLoS Genet"},{"issue":"17","key":"975_CR10","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1093\/hmg\/dds214","volume":"21","author":"F Maltecca","year":"2012","unstructured":"Maltecca F et al (2012) Respiratory dysfunction by AFG3L2 deficiency causes decreased mitochondrial calcium uptake via organellar network fragmentation. Hum Mol Genet 21(17):3858\u20133870","journal-title":"Hum Mol Genet"},{"key":"975_CR11","doi-asserted-by":"publisher","unstructured":"Consolato F et al (2018) m-AAA and i-AAA complexes coordinate to regulate OMA1, the stress-activated supervisor of mitochondrial dynamics. J Cell Sci 131(7):jcs213546. https:\/\/doi.org\/10.1242\/jcs.213546. PMID: 29545505.","DOI":"10.1242\/jcs.213546"},{"issue":"4","key":"975_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.optom.2016.09.003","volume":"10","author":"YL Pilz","year":"2017","unstructured":"Pilz YL, Bass SJ, Sherman J (2017) A review of mitochondrial optic neuropathies: from inherited to acquired forms. J Optom 10(4):205\u2013214","journal-title":"J Optom"},{"key":"975_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fgene.2015.00311","volume":"6","author":"M Charif","year":"2015","unstructured":"Charif M et al (2015) A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability. Front Genet 6:311","journal-title":"Front Genet"},{"issue":"5","key":"975_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3892\/br.2017.987","volume":"7","author":"D Colavito","year":"2017","unstructured":"Colavito D et al (2017) Non-syndromic isolated dominant optic atrophy caused by the p.R468C mutation in the AFG3 like matrix AAA peptidase subunit 2 gene. Biomed Rep 7(5):451\u2013454","journal-title":"Biomed Rep"},{"issue":"12","key":"975_CR15","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/humu.23658","volume":"39","author":"S Magri","year":"2018","unstructured":"Magri S et al (2018) Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation. Hum Mutat 39(12):2060\u20132071","journal-title":"Hum Mutat"},{"key":"975_CR16","doi-asserted-by":"publisher","unstructured":"Caporali L et al (2020) ATPase domain AFG3L2 mutations alter OPA1 processing and cause optic neuropathy. Ann Neurol https:\/\/doi.org\/10.1002\/ana.25723.","DOI":"10.1002\/ana.25723"},{"issue":"11","key":"975_CR17","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1523\/JNEUROSCI.4677-07.2008","volume":"28","author":"F Maltecca","year":"2008","unstructured":"Maltecca F et al (2008) The mitochondrial protease AFG3L2 is essential for axonal development. J Neurosci 28(11):2827\u20132836","journal-title":"J Neurosci"},{"issue":"12","key":"975_CR18","doi-asserted-by":"publisher","first-page":"e1006463","DOI":"10.1371\/journal.pgen.1006463","volume":"12","author":"S Wang","year":"2016","unstructured":"Wang S et al (2016) The mitochondrial m-AAA protease prevents demyelination and hair greying. PLoS Genet 12(12):e1006463","journal-title":"PLoS Genet"},{"issue":"5","key":"975_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.molcel.2019.06.016","volume":"75","author":"C Puchades","year":"2019","unstructured":"Puchades C et al (2019) Unique structural features of the mitochondrial AAA+ protease AFG3L2 reveal the molecular basis for activity in health and disease. Mol Cell 75(5):1073\u20131085 e6","journal-title":"Mol Cell"},{"issue":"1","key":"975_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1172\/JCI74770","volume":"125","author":"F Maltecca","year":"2015","unstructured":"Maltecca F et al (2015) Purkinje neuron Ca2+ influx reduction rescues ataxia in SCA28 model. J Clin Invest 125(1):263\u2013274","journal-title":"J Clin Invest"},{"issue":"1","key":"975_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.molcel.2016.08.020","volume":"64","author":"T Konig","year":"2016","unstructured":"Konig T et al (2016) The m-AAA protease associated with Neurodegeneration limits MCU activity in mitochondria. Mol Cell 64(1):148\u2013162","journal-title":"Mol Cell"},{"issue":"5","key":"975_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ceca.2005.01.014","volume":"37","author":"J Hartmann","year":"2005","unstructured":"Hartmann J, Konnerth A (2005) Determinants of postsynaptic Ca2+ signaling in Purkinje neurons. Cell Calcium 37(5):459\u2013466","journal-title":"Cell Calcium"},{"issue":"3","key":"975_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/cr.2018.17","volume":"28","author":"M Patron","year":"2018","unstructured":"Patron M, Sprenger HG, Langer T (2018) M-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration. Cell Res 28(3):296\u2013306","journal-title":"Cell Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-00975-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-020-00975-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-00975-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T23:23:26Z","timestamp":1624922606000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-020-00975-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["975"],"URL":"https:\/\/doi.org\/10.1186\/s40478-020-00975-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"26 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Subjects\u2019 consent for the study was obtained according to the Declaration of Helsinki and was approved by the ethical committee of The Royal Melbourne Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients signed a consent for publication approved by the ethical committee of The Royal Melbourne Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}